Team: Bios
Todd Foley, MBA
Managing Director
Todd Foley joined MPM's Boston office in 1999 and currently manages the MPM-Novartis BioVentures IV Strategic Fund in addition to investing MPM's main funds. Prior to MPM, Mr. Foley worked in Business Development at Genentech and management consulting with Arthur D. Little. He holds a B.S. in Chemistry from MIT and an M.B.A. from Harvard Business School.
Present Boards
Chiasma, Inc.
CombinatoRx (NASDAQ: CRXX, Formerly NeuroMed)
Peptimmune, Inc. (Observer)
Rhythm Pharmaceuticals
Surface Logix, Inc. (Observer)
Valeritas (Observer)
Past Boards
Alinea Pharmaceuticals, Inc.
BioValve Technologies, Inc. (now Valeritas)
Centagenetix, Inc. (now Elixir)
Coelacanth Corp. (now Lexicon Genetics)
Intracel Holdings Corp.
Primera Biosystems, Inc.
Portfolio Assignments
AVEO Pharmaceuticals, Inc. (formerly GenPath), Founding VP of Business Development
Centagenetix, Inc. (now Elixir), Founding COO